Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,068 | 16,516 | 19,269 | 25,802 | 25,741 |
| Marketable Securities | 12,419 | 24,117 | 31,410 | 33,481 | 45,149 |
| Receivables | 81,047 | 79,931 | 78,736 | 78,881 | 67,039 |
| Inventories | 70,025 | 72,965 | 56,932 | 53,160 | 45,950 |
| TOTAL | $229,400 | $210,923 | $212,841 | $209,014 | $195,187 |
| Non-Current Assets | |||||
| PPE Net | 12,960 | 13,683 | 14,537 | 14,863 | 15,414 |
| Other Non-Current Assets | 6,590 | 7,484 | 8,374 | 9,270 | 10,176 |
| TOTAL | $19,550 | $21,167 | $22,911 | $24,133 | $25,590 |
| Total Assets | $248,950 | $232,090 | $235,752 | $233,147 | $220,777 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,017 | 12,037 | 12,333 | 11,709 | 10,188 |
| Accrued Expenses | 28,411 | 23,606 | 26,511 | 34,956 | 31,390 |
| TOTAL | $89,708 | $258,601 | $88,557 | $91,457 | $85,544 |
| Non-Current Liabilities | |||||
| Long Term Debt | 107,487 | N/A | 25,213 | 25,026 | 24,828 |
| Other Non-Current Liabilities | 36,870 | 747 | 150,435 | 150,315 | 150,410 |
| TOTAL | $144,357 | $747 | $175,648 | $175,341 | $175,238 |
| Total Liabilities | $234,065 | $259,348 | $264,205 | $266,798 | $260,782 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 183,363 | 153,292 | 152,564 | 152,330 | 152,095 |
| Common Shares | 1,833 | 1,533 | 1,524 | 1,521 | 1,517 |
| Retained earnings | -1,936,835 | -1,919,340 | -1,916,959 | -1,919,594 | -1,923,257 |
| Other shareholders' equity | 0 | -1 | 1 | 13 | 40 |
| TOTAL | $14,885 | $-27,258 | $-28,453 | $-33,651 | $-40,005 |
| Total Liabilities And Equity | $248,950 | $232,090 | $235,752 | $233,147 | $220,777 |